Home | Welcome to Contract Pharma   
Last Updated Tuesday, November 25 2014
Print

Trials & Filings in Brief: Sept. 27, 2013



By Gil Roth



Published September 27, 2013
Filings
CSL Behring's Hizentra cleared to treat PID in Japan . . . read more

Durata files NDA for ABSSSI treatment . . . read more

Zalicus gets orphan designation for Z160 . . . read more

Post-Approval
Good data for Novartis' Lucentis . . . read more


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On